-
1
-
-
0027475388
-
LY248686, a new inhibitor of serotonin and norepinephrine uptake
-
Wong DT, Bymaster FP, Mayle DA, Reid LR, Krushinski JH, Robertson DW. LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology 1993; 8: 23-33.
-
(1993)
Neuropsychopharmacology
, vol.8
, pp. 23-33
-
-
Wong, D.T.1
Bymaster, F.P.2
Mayle, D.A.3
Reid, L.R.4
Krushinski, J.H.5
Robertson, D.W.6
-
2
-
-
0029027862
-
Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat
-
Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 1995; 274: 1014-24.
-
(1995)
J Pharmacol Exp Ther
, vol.274
, pp. 1014-1024
-
-
Thor, K.B.1
Katofiasc, M.A.2
-
3
-
-
0028935452
-
Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats
-
Katoh A, Eigyo M, Ishibashi C et al. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats. J Pharmacol Exp Ther 1995; 272: 1067-75.
-
(1995)
J Pharmacol Exp Ther
, vol.272
, pp. 1067-1075
-
-
Katoh, A.1
Eigyo, M.2
Ishibashi, C.3
-
4
-
-
0033674519
-
Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor
-
Sharma A, Goldberg MJ, Cerimele BJ. Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor. J Clin Pharmacol 2000; 40: 161-7.
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 161-167
-
-
Sharma, A.1
Goldberg, M.J.2
Cerimele, B.J.3
-
5
-
-
0023922788
-
Pharmacodynamic basis for altered drug action in the elderly
-
Roberts J, Tumer N. Pharmacodynamic basis for altered drug action in the elderly. Clin Geriatr Med 1988; 4: 127-49.
-
(1988)
Clin Geriatr Med
, vol.4
, pp. 127-149
-
-
Roberts, J.1
Tumer, N.2
-
7
-
-
0030982413
-
Clinical pharmacokinetic considerations in the elderly. An update
-
Kinirons MT, Crome P. Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet 1997; 33: 302-12.
-
(1997)
Clin Pharmacokinet
, vol.33
, pp. 302-312
-
-
Kinirons, M.T.1
Crome, P.2
-
8
-
-
0024447750
-
Clinical pharmacokinetic considerations in the elderly. An update
-
Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet 1989; 17: 236-63.
-
(1989)
Clin Pharmacokinet
, vol.17
, pp. 236-263
-
-
Dawling, S.1
Crome, P.2
-
9
-
-
0030003060
-
High performance liquid chromatographic method for the determination of duloxetine and desmethyl duloxetine in human plasma
-
Johnson JT, Oldham SW, Lantz RJ, DeLong AF. High performance liquid chromatographic method for the determination of duloxetine and desmethyl duloxetine in human plasma. J Liq Chrom Rel Technol 1996; 19: 1631-41.
-
(1996)
J Liq Chrom Rel Technol
, vol.19
, pp. 1631-1641
-
-
Johnson, J.T.1
Oldham, S.W.2
Lantz, R.J.3
DeLong, A.F.4
-
10
-
-
0344761710
-
-
University of California, San Francisco: NONMEM Project Group
-
Beal SL, Sheiner LB. NONMEM users guide, Part VII, Conditional estimation methods. University of California, San Francisco: NONMEM Project Group, 1992.
-
(1992)
NONMEM Users Guide, Part VII, Conditional Estimation Methods
-
-
Beal, S.L.1
Sheiner, L.B.2
-
11
-
-
0347279967
-
A population pharmacokinetic analysis of gemcitabine following variable length infusions
-
Abstr. 8178
-
Allerheiligen S, Cerimele B, Milosevich S, Johnson R, Nelson R, Tarassoff P. A population pharmacokinetic analysis of gemcitabine following variable length infusions. Pharmaceutical Res 1994; 11 (Abstr. 8178): S-377.
-
(1994)
Pharmaceutical Res
, vol.11
-
-
Allerheiligen, S.1
Cerimele, B.2
Milosevich, S.3
Johnson, R.4
Nelson, R.5
Tarassoff, P.6
-
12
-
-
85081428990
-
Challenging the robustness of a population pharmacokinetic model obtained from a Phase III raloxifene study
-
AAPS Annual Meeting and Exposition 1998. Abstr. 3548
-
O'Brien L, Hewitt R, Heathman M, Ni L, Allerheiligen S. Challenging the robustness of a population pharmacokinetic model obtained from a Phase III raloxifene study. AAPS Annual Meeting and Exposition 1998. AAPS Pharm Sci 1998; 1 (Abstr. 3548).
-
(1998)
AAPS Pharm Sci
, vol.1
-
-
O'Brien, L.1
Hewitt, R.2
Heathman, M.3
Ni, L.4
Allerheiligen, S.5
-
13
-
-
0041856533
-
Metabolism, excretion, and pharmokinetics of duloxetine in healthy human subjects
-
Lantz RJ, Gillespie TA, Rash TJ, Kuo F, Skinner M, Kuan HY, Knadler MP. Metabolism, excretion, and pharmokinetics of duloxetine in healthy human subjects. Drug Metab Disp 2003; 31: 1142-50.
-
(2003)
Drug Metab Disp
, vol.31
, pp. 1142-1150
-
-
Lantz, R.J.1
Gillespie, T.A.2
Rash, T.J.3
Kuo, F.4
Skinner, M.5
Kuan, H.Y.6
Knadler, M.P.7
-
14
-
-
0014381929
-
Effect of age on intestinal absorption: Implications for drug absorption in the elderly
-
Bender A. Effect of age on intestinal absorption: implications for drug absorption in the elderly. J Am Geriatr Soc 1968; 16: 1331-9.
-
(1968)
J Am Geriatr Soc
, vol.16
, pp. 1331-1339
-
-
Bender, A.1
-
16
-
-
0019451134
-
Gastric emptying rate in the elderly
-
Evens MA, Triggs EJ, Cheung M, Broe GA, Creasey H. Gastric emptying rate in the elderly. J Am Geriatr Soc 1981; 29: 201-5.
-
(1981)
J Am Geriatr Soc
, vol.29
, pp. 201-205
-
-
Evens, M.A.1
Triggs, E.J.2
Cheung, M.3
Broe, G.A.4
Creasey, H.5
|